Imeik Technology Development Co (300896.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · China · ISIN CNE100004868

Price
98.01 CNY
Market cap
29.52 bn CNY
P/E (2025)
–
P/S (2025)
12.18
Dividend yield
1.84 %
Net margin
53.26 %
Return on equity (ROE)
15.81 %
Return on assets (ROA)
14.49 %

Imeik Technology Development Co financials

Fiscal year20242025
Revenue3.03 bn CNY2.42 bn CNY
Gross profit2.86 bn CNY2.19 bn CNY
Operating income2.29 bn CNY1.32 bn CNY
EBIT2.28 bn CNY1.32 bn CNY
Net income1.96 bn CNY1.29 bn CNY
Diluted EPS – continuing operations6.50 CNY–

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Imeik Technology Development Co

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; and skin care products. It serves medical aesthetic institutions. The company was incorporated in 2004 and is headquartered in Beijing, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.

Imeik Technology Development Co stock (300896.SZ): P/E, revenue, dividend | finmetric